Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Phillips

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
International Journal of Stroke : Official Journal of the International Stroke Society|April 27, 2017
Canadian Stroke Best Practice Recommendations: Telestroke Best Practice Guidelines Update 2017Dylan Blacquiere, M Patrice Lindsay, Norine Foley, et al.
Stroke (Hoboken, N.J.)|May 8, 2026
AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical TrialTolulope Sajobi, Nishita Singh, Mohammed A Almekhlafi, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 8, 2014
Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 MinutesNoreen Kamal, Oscar Benavente, Karl Boyle, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 21, 2023
Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trialFouzi Bala, Mohammed Almekhlafi, Nishita Singh, et al.
JAMA Neurology|July 10, 2023
Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical TrialFouzi Bala, Nishita Singh, Brian Buck, et al.
Stroke|January 4, 2024
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus TenecteplaseDiana J Kim, Nishita Singh, Luciana Catanese, et al.
Lancet (London, England)|July 2, 2022
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialBijoy K Menon, Brian H Buck, Nishita Singh, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
International Journal of Stroke : Official Journal of the International Stroke Society|April 27, 2017
Canadian Stroke Best Practice Recommendations: Telestroke Best Practice Guidelines Update 2017Dylan Blacquiere, M Patrice Lindsay, Norine Foley, et al.
Stroke (Hoboken, N.J.)|May 8, 2026
AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical TrialTolulope Sajobi, Nishita Singh, Mohammed A Almekhlafi, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 8, 2014
Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 MinutesNoreen Kamal, Oscar Benavente, Karl Boyle, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 21, 2023
Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trialFouzi Bala, Mohammed Almekhlafi, Nishita Singh, et al.
JAMA Neurology|July 10, 2023
Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical TrialFouzi Bala, Nishita Singh, Brian Buck, et al.
Stroke|January 4, 2024
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus TenecteplaseDiana J Kim, Nishita Singh, Luciana Catanese, et al.
Lancet (London, England)|July 2, 2022
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialBijoy K Menon, Brian H Buck, Nishita Singh, et al.
Pageof 8